CSPHF Stock Price, Chart, Stats & News

CStone Pharmaceuticals
Save
CStone Pharmaceuticals (CSPHF) does not currently pay a dividend.
1.12B
Market cap
–
Current P/E
–
Forward P/E
CSPHF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
CStone Pharmaceuticals is a biopharmaceutical firm dedicated to discovering, developing, and marketing innovative immuno-oncology and precision medicine therapies. Their primary objective is to fulfill critical medical requirements for cancer patients, both within China and across global markets. The company currently provides several key therapeutic agents.
Similar securities
Based on sector and market capitalization
Report issue





